Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 767

1.

High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.

Cheng PN, Jen CM, Young KC, Chen CY, Lu SN, Wang CS, Chang TT.

Hepatogastroenterology. 2003 Mar-Apr;50(50):449-52.

PMID:
12749244
2.

Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.

Berg T, Hoffmann RM, Teuber G, Leifeld L, Lafrenz M, Baumgarten R, Spengler U, Zeuzem S, Pape GR, Hopf U.

Liver. 2000 Dec;20(6):427-36.

PMID:
11169056
3.

Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial.

Barbaro G, Di Lorenzo G, Belloni G, Ferrari L, Paiano A, Del Poggio P, Bacca D, Fruttaldo L, Mongiò F, Francavilla R, Scotto G, Grisorio B, Calleri G, Annese M, Barelli A, Rocchetto P, Rizzo G, Gualandi G, Poltronieri I, Barbarini G.

Am J Med. 1999 Aug;107(2):112-8.

PMID:
10460040
4.
5.

Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.

de Lédinghen V, Trimoulet P, Winnock M, Bernard PH, Bourlière M, Portal I, Rémy AJ, Szostak N, Lévy S, Tran A, Abergel A, Chêne G, Fleury H, Couzigou P; French Multicenter Study Group.

J Hepatol. 2002 Jun;36(6):819-26.

PMID:
12044534
6.
7.
8.

Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.

Kao JH, Lai MY, Chen W, Chen PJ, Chen DS.

J Gastroenterol Hepatol. 1998 Dec;13(12):1249-53.

PMID:
9918434
9.

Clinical comparison of high-dose interferon-alpha2b with or without ribavirin for treatment of interferon-relapsed chronic hepatitis C.

Cheng PN, Chow NH, Hu SC, Young KC, Chen CY, Jen CM, Chang TT.

Dig Liver Dis. 2002 Dec;34(12):851-6.

PMID:
12643293
10.

Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C.

Younossi ZM, Mullen KD, Hodnick S, Barnes DS, Carey WD, McCullough AC, Easley K, Gramlich T, Liebermann BY.

J Clin Gastroenterol. 2003 May-Jun;36(5):427-30.

PMID:
12702987
11.

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study.

Benetti G, Borzio M, Ramella G, Bellati G, Fargion S, Colombo A, Croce G, Iamoletti C, Balzola F, Rizzetto M; GEL (Gruppo Epatologico Lombardo).

Intern Emerg Med. 2006;1(2):113-8.

PMID:
17111783
12.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

14.

Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.

Di Marco V, Ferraro D, Almasio P, Vaccaro A, Parisi P, Cappello M, Cino N, Di Stefano R, Craxì A.

J Viral Hepat. 2002 Sep;9(5):354-9.

PMID:
12225330
15.

High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load.

Tsubota A, Arase Y, Suzuki F, Suzuki Y, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H.

J Gastroenterol. 2004;39(2):155-61.

PMID:
15069622
16.

Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.

Tomimatsu M, Aizawa Y, Chuganji Y, Ishizuka H, Fujita Y, Aizawa R, Abe H, Matsuda T, Itou Y, Nakanishi H, Ushiyama H, Higuchi T, Fujimoto T, Endou H, Iga D, Ohta K, Kuroda H.

J Gastroenterol Hepatol. 2006 Jul;21(7):1177-83.

PMID:
16824072
17.

High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.

da Silva LC, Bassit L, Ono-Nita SK, Pinho JR, Nishiya A, Madruga CL, Carrilho FJ.

J Gastroenterol. 2002;37(9):732-6.

PMID:
12375147
18.

First-line therapy with daily versus thrice-weekly interferon alfa-2b plus ribavirin for chronic hepatitis C.

Reiser M, Buggisch P, Grossmann J, Koop K, Wursthorn K, Schmiegel W.

Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1299-304.

PMID:
14624153
19.

[Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C].

Kim CH, Park BD, Lee JW, Kim YS, Jeong S, Lee DH, Kim HG, Shin YW, Kwon KS, Lee JI.

Korean J Hepatol. 2009 Mar;15(1):70-9. doi: 10.3350/kjhep.2009.15.1.70. Korean.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk